enGene Therapeutics Inc. (ENGN): 8-K filed Jul 17, 2026

Form type

8-K

Filing date

Jul 17, 2026

Accession number

0001193125-26-307795

Filer

enGene Therapeutics Inc. (CIK 1980845)